Seilern Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.4M Buy
97,560
+16,729
+21% +$9.38M 6.47% 5
2026
Q1
$45.4M Sell
80,831
-19,959
-20% -$12.8M 5.42% 10
2025
Q4
$68.2M Sell
100,790
-40,486
-29% -$27.6M 5.29% 13
2025
Q3
$90.3M Sell
141,276
-70,900
-33% -$43M 6.52% 5
2025
Q2
$114M Sell
212,176
-53,773
-20% -$25.7M 7.51% 4
2025
Q1
$112M Sell
265,949
-7,618
-3% -$3.31M 7.3% 4
2024
Q4
$113M Buy
+273,567
New +$120M 6.44% 5

Other funds holding IDXX

Seilern Investment Management's IDXX Position: Q2 2026 in Review

Seilern Investment Management increased its Idexx Laboratories (IDXX) stake by 21% in Q2 2026, buying an estimated $9.38M and bringing the position to 97,560 shares worth $51.4M. The position accounts for 6.47% of the portfolio, ranked #5.

Seilern Investment Management first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $114M in Q2 2025. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Seilern Investment Management held 97,560 shares of Idexx Laboratories worth $51.4M as of Q2 2026.
  • Seilern Investment Management bought 16,729 Idexx Laboratories shares in Q2 2026, an estimated $9.38M.
  • Idexx Laboratories made up 6.47% of Seilern Investment Management's portfolio in Q2 2026, its #5 holding.
  • Seilern Investment Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Seilern Investment Management's Idexx Laboratories position peaked at $114M in Q2 2025.
  • 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Seilern Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.